SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-004786
Filing Date
2017-08-07
Accepted
2017-08-07 17:01:13
Documents
46
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080817p.htm 10-Q 765096
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8417
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7524
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5428
  Complete submission text file 0001171843-17-004786.txt   2634396

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE prto-20170630.xml EX-101.INS 326883
6 XBRL SCHEMA FILE prto-20170630.xsd EX-101.SCH 29759
7 XBRL CALCULATION FILE prto-20170630_cal.xml EX-101.CAL 25644
8 XBRL DEFINITION FILE prto-20170630_def.xml EX-101.DEF 216840
9 XBRL LABEL FILE prto-20170630_lab.xml EX-101.LAB 184367
10 XBRL PRESENTATION FILE prto-20170630_pre.xml EX-101.PRE 228343
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 171012223
SIC: 2836 Biological Products, (No Diagnostic Substances)